Xenetic Net Receivables vs Total Revenue Analysis

XBIO Stock  USD 4.21  0.05  1.17%   
Xenetic Biosciences financial indicator trend analysis is more than just analyzing Xenetic Biosciences current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xenetic Biosciences is a good investment. Please check the relationship between Xenetic Biosciences Net Receivables and its Total Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.

Net Receivables vs Total Revenue

Net Receivables vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xenetic Biosciences Net Receivables account and Total Revenue. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Xenetic Biosciences' Net Receivables and Total Revenue is 0.1. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Xenetic Biosciences, assuming nothing else is changed. The correlation between historical values of Xenetic Biosciences' Net Receivables and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Xenetic Biosciences are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Net Receivables i.e., Xenetic Biosciences' Net Receivables and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.1
Relationship DirectionPositive 
Relationship StrengthInsignificant

Net Receivables

Total Revenue

Total revenue comprises all receipts Xenetic Biosciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most indicators from Xenetic Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xenetic Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.At this time, Xenetic Biosciences' Selling General Administrative is very stable compared to the past year. As of the 3rd of December 2024, Enterprise Value Over EBITDA is likely to grow to 0.86, while Issuance Of Capital Stock is likely to drop 0.00.

Xenetic Biosciences fundamental ratios Correlations

0.180.240.40.92-0.53-0.46-0.430.440.470.620.470.050.60.53-0.710.560.350.00.180.250.020.150.24-0.33-0.18
0.180.010.41-0.010.640.280.690.14-0.230.47-0.230.310.470.510.21-0.240.860.83-0.6-0.11-0.50.07-0.820.830.64
0.240.010.83-0.03-0.280.19-0.160.73-0.190.29-0.190.360.270.63-0.43-0.05-0.020.32-0.160.63-0.030.820.03-0.2-0.27
0.40.410.830.04-0.080.290.060.86-0.270.57-0.270.240.550.88-0.42-0.120.270.64-0.310.61-0.260.83-0.250.10.0
0.92-0.01-0.030.04-0.6-0.72-0.560.110.730.350.73-0.080.340.18-0.650.770.22-0.280.40.040.23-0.140.45-0.45-0.23
-0.530.64-0.28-0.08-0.60.60.97-0.23-0.560.03-0.560.220.060.010.81-0.630.430.6-0.73-0.24-0.61-0.17-0.910.940.77
-0.460.280.190.29-0.720.60.660.35-1.00.36-1.00.260.350.390.43-0.970.120.5-0.720.23-0.670.31-0.670.50.36
-0.430.69-0.160.06-0.560.970.66-0.08-0.610.19-0.610.220.230.190.77-0.660.450.64-0.77-0.14-0.73-0.03-0.950.950.81
0.440.140.730.860.11-0.230.35-0.08-0.340.72-0.340.230.720.9-0.54-0.180.110.43-0.180.65-0.40.74-0.05-0.150.0
0.47-0.23-0.19-0.270.73-0.56-1.0-0.61-0.34-0.321.0-0.24-0.31-0.35-0.430.97-0.08-0.460.7-0.240.61-0.310.63-0.45-0.28
0.620.470.290.570.350.030.360.190.72-0.32-0.320.320.990.88-0.35-0.250.550.45-0.370.27-0.660.27-0.340.140.32
0.47-0.23-0.19-0.270.73-0.56-1.0-0.61-0.341.0-0.32-0.24-0.31-0.35-0.430.97-0.08-0.460.7-0.240.61-0.310.63-0.45-0.28
0.050.310.360.24-0.080.220.260.220.23-0.240.32-0.240.320.32-0.14-0.270.640.54-0.31-0.14-0.23-0.06-0.330.190.19
0.60.470.270.550.340.060.350.230.72-0.310.99-0.310.320.87-0.31-0.250.540.45-0.360.26-0.690.27-0.360.170.37
0.530.510.630.880.180.010.390.190.9-0.350.88-0.350.320.87-0.4-0.230.450.64-0.390.5-0.560.64-0.350.170.24
-0.710.21-0.43-0.42-0.650.810.430.77-0.54-0.43-0.35-0.43-0.14-0.31-0.4-0.51-0.050.09-0.49-0.27-0.34-0.23-0.630.70.47
0.56-0.24-0.05-0.120.77-0.63-0.97-0.66-0.180.97-0.250.97-0.27-0.25-0.23-0.51-0.13-0.450.630.00.6-0.120.66-0.51-0.34
0.350.86-0.020.270.220.430.120.450.11-0.080.55-0.080.640.540.45-0.05-0.130.73-0.43-0.28-0.38-0.19-0.610.580.51
0.00.830.320.64-0.280.60.50.640.43-0.460.45-0.460.540.450.640.09-0.450.73-0.590.05-0.50.28-0.770.720.54
0.18-0.6-0.16-0.310.4-0.73-0.72-0.77-0.180.7-0.370.7-0.31-0.36-0.39-0.490.63-0.43-0.59-0.350.67-0.260.84-0.7-0.5
0.25-0.110.630.610.04-0.240.23-0.140.65-0.240.27-0.24-0.140.260.5-0.270.0-0.280.05-0.35-0.10.830.07-0.22-0.26
0.02-0.5-0.03-0.260.23-0.61-0.67-0.73-0.40.61-0.660.61-0.23-0.69-0.56-0.340.6-0.38-0.50.67-0.1-0.120.7-0.57-0.77
0.150.070.820.83-0.14-0.170.31-0.030.74-0.310.27-0.31-0.060.270.64-0.23-0.12-0.190.28-0.260.83-0.12-0.06-0.05-0.19
0.24-0.820.03-0.250.45-0.91-0.67-0.95-0.050.63-0.340.63-0.33-0.36-0.35-0.630.66-0.61-0.770.840.070.7-0.06-0.95-0.7
-0.330.83-0.20.1-0.450.940.50.95-0.15-0.450.14-0.450.190.170.170.7-0.510.580.72-0.7-0.22-0.57-0.05-0.950.76
-0.180.64-0.270.0-0.230.770.360.810.0-0.280.32-0.280.190.370.240.47-0.340.510.54-0.5-0.26-0.77-0.19-0.70.76
Click cells to compare fundamentals

Xenetic Biosciences Account Relationship Matchups

Xenetic Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets21.5M13.2M19.8M14.7M10.6M18.0M
Other Current Liab484.0K609.5K1.0M785.8K568.8K997.5K
Total Current Liabilities1.4M936.9K1.4M1.1M809.6K1.6M
Total Stockholder Equity17.2M12.2M18.4M13.6M9.8M13.7M
Net Debt(10.3M)(11.5M)(18.2M)(13.1M)(9.0M)(9.4M)
Retained Earnings(166.0M)(176.9M)(182.5M)(189.1M)(193.2M)(202.9M)
Accounts Payable931.1K327.4K362.5K287.4K240.8K228.8K
Cash10.4M11.5M18.2M13.1M9.0M7.7M
Non Current Assets Total10.5M810.0K1.1M1.1M1.0M967.4K
Cash And Short Term Investments10.4M11.5M18.2M13.1M9.0M7.7M
Common Stock Total Equity9.0K9.7K6.1K8.8K7.9K7.5K
Liabilities And Stockholders Equity21.5M13.2M19.8M14.7M10.6M18.0M
Total Liab4.3M964.0K1.4M1.1M809.6K769.1K
Total Current Assets11.1M12.4M18.7M13.7M9.6M8.9M
Common Stock6.1K8.8K13.5K15.2K1.5K1.5K
Non Currrent Assets Other1.2M782.9K1.1M1.1M1.0M697.2K
Common Stock Shares Outstanding285.2K639.2K1.0M1.4M1.5M1.6M
Other Current Assets722.1K225K252.4K556.1K603.8K617.8K
Other Stockholder Equity183.0M188.9M200.7M202.5M202.8M162.6M
Net Tangible Assets(2.6M)8.0M12.2M18.4M21.2M22.2M
Retained Earnings Total Equity(145.9M)(153.2M)(166.0M)(176.9M)(159.2M)(167.2M)
Capital Surpluse165.2M168.2M188.2M194.1M223.3M157.1M
Property Plant Equipment27.8K5.0K757.027.0K24.3K43.7K
Other Assets705.7K1.2M810.0K1.1M1.3M679.4K
Net Invested Capital17.2M12.2M18.4M13.6M9.8M10.9M
Net Working Capital9.7M11.4M17.3M12.6M8.8M9.9M
Capital Stock8.9K11.5K16.2K18.0K3.3K3.2K

Pair Trading with Xenetic Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xenetic Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenetic Biosciences will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Xenetic Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xenetic Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xenetic Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xenetic Biosciences to buy it.
The correlation of Xenetic Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xenetic Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xenetic Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xenetic Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Xenetic Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xenetic Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xenetic Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xenetic Biosciences Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.66)
Revenue Per Share
1.638
Quarterly Revenue Growth
0.116
Return On Assets
(0.29)
Return On Equity
(0.49)
The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.